Komori
YASKAWA Electric (6506) · FactDecline in interim R&D expenses and ratio

R&D expenses of ¥4.702 billion and R&D expenses-to-net-sales ratio of 4.4%

First written in FY2018-Q2. . Latest entry: FY2027-H1.

34entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q2 – FY2027-H12017: 220172018: 420182019: 420192020: 420202021: 420212022: 420222023: 420232024: 420242025: 220252026: 22026
Same theme, other companies
Continuation of Company-wide R&D Activities and Resource InvestmentA theme 204 companies write about · 0 as a headwind · 217 as a tailwind

90 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 186 companies compared. The sentences above are computed from all 186.Comparing 200 of the theme's 219 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Decline in interim R&D expenses and ratioAnnual report

    「The Company's R&D expenses during the interim consolidated accounting period amounted to ¥11,577 million.」

    Interim R&D expenses amounted to ¥11,577 million, down from ¥11,876 million in the same period of the previous year. The ratio of R&D expenses to revenue also declined from 4.6% to 4.1%.
  2. FY2026Increase in full-year R&D expensesAnnual report

    「As a result of these initiatives, research and development expenses for the fiscal year amounted to ¥24,006 million.」

    Research and development expenses increased from ¥23,773 million in the previous fiscal year to ¥24,006 million. Development continued in AI robotics, i³-Mechatronics, physical AI, and applied fields.
  3. FY2026-H1Slight decline in first-half research and development expenses, with the ratio increasingAnnual report

    「Research and development expenses for the interim consolidated period amounted to ¥11,876 million.」

    Research and development expenses declined slightly from ¥11,894 million in the same period of the previous year to ¥11,876 million, while research and development expenses as a percentage of revenue increased from 4.5% to 4.6%.
  4. FY2025Full-year research and development expenses: ¥23,773 millionAnnual report

    「As a result of these initiatives, research and development expenses for the fiscal year amounted to ¥23,773 million.」

    Full-year research and development expenses amounted to ¥23,773 million, up from ¥21,247 million in the previous fiscal year.
  5. FY2025-H1First-half research and development expenses: ¥11,894 million; ratio: 4.5%Annual report

    「Research and development expenses for the interim consolidated period amounted to ¥11,894 million.」

    FY2025-H1 research and development expenses amounted to ¥11,894 million, and research and development expenses as a percentage of revenue were 4.5%. Compared with ¥10,305 million and 3.6% in the same period of the previous year, both expenses and the ratio increased.
  6. FY2025-Q1First-quarter research and development expenses: ¥5,984 million; ratio: 4.5%Annual report

    「Research and development expenses for the first-quarter cumulative consolidated period amounted to ¥5,984 million.」

    First-quarter research and development expenses amounted to ¥5,984 million, and research and development expenses as a percentage of revenue were 4.5%, up from ¥4,931 million and 3.5% in the same quarter of the previous year.
  7. FY2024Full-year research and development expenses: ¥21,247 millionAnnual report

    「As a result of these initiatives, research and development expenses for the fiscal year amounted to ¥21,247 million.」

    FY2024 research and development expenses amounted to ¥21,247 million, up from ¥18,778 million in the previous fiscal year.
  8. FY2024-Q3Nine-month cumulative research and development expenses: ¥15,953 million; ratio: 3.8%Annual report

    「Research and development expenses for the nine-month cumulative consolidated period amounted to ¥15,953 million.」

    Research and development expenses for the nine-month cumulative period amounted to ¥15,953 million, and research and development expenses as a percentage of revenue were 3.8%, up from ¥13,759 million and 3.4% in the same period of the previous year.
  9. FY2024-Q2First-half research and development expenses: ¥10,305 million; ratio: 3.6%Annual report

    「Research and development expenses for the first-half cumulative consolidated period amounted to ¥10,305 million.」

    Research and development expenses for the first-half cumulative period amounted to ¥10,305 million, and research and development expenses as a percentage of revenue were 3.6%. Compared with ¥9,184 million and 3.5% in the same period of the previous year, both expenses and the ratio increased.
  10. FY2024-Q1First-quarter research and development expenses: ¥4,931 million; ratio: 3.5%Annual report

    「Research and development expenses for the first-quarter cumulative consolidated period amounted to ¥4,931 million.」

    First-quarter research and development expenses amounted to ¥4,931 million, up from ¥4,311 million in the same quarter of the previous year. Research and development expenses as a percentage of revenue were 3.5%, down from 3.6% in the same quarter of the previous year.
  11. FY2023Full-year research and development expenses: ¥18,778 millionAnnual report

    「As a result of these initiatives, research and development expenses for the fiscal year amounted to ¥18,778 million.」

    Full-year research and development expenses amounted to ¥18,778 million, up from ¥18,175 million in the previous fiscal year.
  12. FY2023-Q3Nine-month cumulative research and development expenses: ¥13,759 million; ratio: 3.4%Annual report

    「Research and development expenses for the nine-month cumulative consolidated period amounted to ¥13,759 million.」

    Research and development expenses for the nine-month cumulative period amounted to ¥13,759 million, and research and development expenses as a percentage of revenue were 3.4%. Compared with ¥13,696 million and 3.8% in the same period of the previous year, expenses increased while the ratio declined.
  13. FY2023-Q2First-half research and development expenses: ¥9,184 million; ratio: 3.5%Annual report

    「Research and development expenses for the first-half cumulative consolidated period amounted to ¥9,184 million.」

    Research and development expenses for the first-half cumulative period amounted to ¥9,184 million, and research and development expenses as a percentage of revenue were 3.5%. Compared with ¥9,074 million and 3.8% in the same period of the previous year, expenses increased while the ratio declined.
  14. FY2023-Q1First-quarter research and development expenses: ¥4,311 million; ratio: 3.6%Annual report

    「Research and development expenses for the first-quarter cumulative consolidated period amounted to ¥4,311 million.」

    First-quarter research and development expenses amounted to ¥4,311 million, and research and development expenses as a percentage of revenue were 3.6%.
  15. FY2022Full-year research and development expenses: ¥18,175 millionAnnual report

    「As a result of these initiatives, research and development expenses for the fiscal year amounted to ¥18,175 million.」

    Full-year research and development expenses amounted to ¥18,175 million, up from ¥17,851 million in the previous fiscal year.
  16. FY2022-Q3Nine-month cumulative research and development expenses: ¥13,696 million; ratio: 3.8%Annual report

    「Research and development expenses for the nine-month cumulative consolidated period amounted to ¥13,696 million.」

    Research and development expenses for the nine-month cumulative period amounted to ¥13,696 million, and research and development expenses as a percentage of revenue were 3.8%. Compared with ¥13,005 million and 4.6% in the same period of the previous year, expenses increased while the ratio declined.
  17. FY2022-Q2First-half research and development expenses: ¥9,074 million; ratio: 3.8%Annual report

    「Research and development expenses for the first-half cumulative consolidated period amounted to ¥9,074 million.」

    Research and development expenses for the first-half cumulative period amounted to ¥9,074 million, and research and development expenses as a percentage of revenue were 3.8%.
  18. FY2022-Q1First-quarter research and development expenses: ¥4,506 million; ratio: 3.8%Annual report

    「Research and development expenses for the first-quarter cumulative consolidated period amounted to ¥4,506 million.」

    First-quarter research and development expenses amounted to ¥4,506 million, and research and development expenses as a percentage of revenue were 3.8%. While research and development expenses increased year on year, the ratio declined from 4.7%.
  19. FY2021Full-year research and development expenses: ¥17,851 millionAnnual report

    「As a result of these initiatives, research and development expenses for the fiscal year amounted to ¥17,851 million.」

    Full-year research and development expenses amounted to ¥17,851 million, down from ¥18,999 million in the previous fiscal year, while development continued for i3-Mechatronics, IoT, AI, and applied fields.
  20. FY2021-Q3Nine-month cumulative research and development expenses: ¥13,005 million; ratio: 4.6%Annual report

    「Research and development expenses for the nine-month cumulative consolidated period amounted to ¥13,005 million.」

    Research and development expenses for the nine-month cumulative period amounted to ¥13,005 million, and research and development expenses as a percentage of revenue were 4.6%. In the same period of the previous year, they were ¥14,118 million and 4.6%, respectively.
  21. FY2021-Q2First-half research and development expenses: ¥8,900 million; ratio: 4.8%Annual report

    「Research and development expenses for the first-half cumulative consolidated period amounted to ¥8,900 million.」

    Research and development expenses for the first-half cumulative period amounted to ¥8,900 million, and research and development expenses as a percentage of revenue were 4.8%. Compared with ¥9,682 million and 4.6% in the same period of the previous year, expenses decreased while the ratio increased.
  22. FY2021-Q1First-quarter research and development expenses: ¥4,276 million; ratio: 4.7%Annual report

    「Research and development expenses for the first-quarter cumulative consolidated period amounted to ¥4,276 million.」

    FY2021-Q1 research and development expenses amounted to ¥4,276 million, and research and development expenses as a percentage of revenue were 4.7%. Compared with ¥4,659 million and 4.3% in the same quarter of the previous year, expenses decreased while the ratio increased.
  23. FY2020Full-year R&D expenses: ¥18,999 millionAnnual report

    「As a result of these initiatives, research and development expenses for the fiscal year amounted to ¥18,999 million.」

    Full-year research and development expenses amounted to ¥18,999 million, as research and development continued for i³-Mechatronics, YRM controllers, AI and IoT, and products for applied fields.
  24. FY2020-Q3Cumulative R&D expenses through the third quarter: ¥14,118 million; ratio: 4.6%Annual report

    「As a result of these initiatives, R&D expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥14,118 million.」

    Cumulative R&D expenses through the third quarter amounted to ¥14,118 million, and R&D expenses as a percentage of net sales were 4.6%, compared with ¥14,814 million and 4.1% in the same period of the previous year.
  25. FY2020-Q2First-half R&D expenses: ¥9,682 million; ratio: 4.6%Annual report

    「As a result of these initiatives, R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥9,682 million.」

    Cumulative R&D expenses through the second quarter amounted to ¥9,682 million, down from ¥9,981 million in the same period of the previous year, while R&D expenses as a percentage of net sales rose from 4.0% to 4.6%.
  26. FY2020-Q1First-quarter R&D expenses: ¥4,659 million; ratio: 4.3%Annual report

    「As a result of these initiatives, R&D expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥4,659 million.」

    R&D expenses for the first quarter amounted to ¥4,659 million, and R&D expenses as a percentage of net sales were 4.3%.
  27. FY2019Full-year R&D expenses: ¥20,792 millionAnnual report

    「R&D expenses for the current consolidated fiscal year amounted to ¥20,792 million. The status in each field is as follows.」

    Full-year R&D expenses amounted to ¥20,792 million, up from ¥19,072 million in the previous fiscal year.
  28. FY2019-Q3Cumulative R&D expenses through the third quarter: ¥14,814 million; ratio: 4.1%Annual report

    「R&D expenses of the Group for the cumulative third quarter of the current consolidated fiscal year amounted to ¥14,814 million.」

    Cumulative R&D expenses through the third quarter amounted to ¥14,814 million, and R&D expenses as a percentage of net sales were 4.1%.
  29. FY2019-Q2First-half R&D expenses: ¥9,981 million; ratio: 4.0%Annual report

    「As a result of these initiatives, R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥9,981 million.」

    Cumulative R&D expenses through the second quarter amounted to ¥9,981 million, and R&D expenses as a percentage of net sales were 4.0%.
  30. FY2019-Q1First-quarter R&D expenses and ratioAnnual report

    「As a result of these initiatives, R&D expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥4,679 million.」

    First-quarter R&D expenses amounted to ¥4,679 million, and R&D expenses as a percentage of net sales were 3.6%.
  31. FY2018Full-year R&D expenses: ¥19,072 millionAnnual report

    「R&D expenses for the current consolidated fiscal year amounted to ¥19,072 million. The status in each field is as follows.」

    Full-year R&D expenses amounted to ¥19,072 million, up from ¥17,979 million in the previous fiscal year. R&D focused on i3-Mechatronics, IoT, AI and open innovation was promoted.
  32. FY2018-Q4Cumulative R&D expenses through the third quarter: ¥13,920 million; ratio: 4.1%Annual report

    「As a result of these initiatives, R&D expenses for the cumulative third quarter of the current consolidated fiscal year amounted to ¥13,920 million.」

    Cumulative R&D expenses through the third quarter amounted to ¥13,920 million, and R&D expenses as a percentage of net sales were 4.1%. R&D expenses increased from ¥13,392 million, or 4.7%, in the same period of the previous year.
  33. FY2018-Q3Cumulative R&D expenses through the second quarter: ¥9,706 million; ratio: 4.2%Annual report

    「As a result of these initiatives, R&D expenses for the cumulative second quarter of the current consolidated fiscal year amounted to ¥9,706 million.」

    Cumulative R&D expenses through the second quarter amounted to ¥9,706 million, and R&D expenses as a percentage of net sales were 4.2%.
  34. FY2018-Q2First statedAnnual report

    「As a result of these initiatives, R&D expenses for the cumulative first quarter of the current consolidated fiscal year amounted to ¥4,702 million.」

    First-quarter R&D expenses were ¥4,702 million, and R&D expenses as a percentage of net sales were 4.4%. R&D expenses increased from ¥4,396 million, or 4.9%, in the same period of the previous year.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
YASKAWA Electric's next results are scheduled for 2026-10-09. Read the earnings preview
News
News that touched this theme
R&D expenses of ¥4.702 billion and R&D expenses-to-net-sales ratio of 4.4% | YASKAWA Electric Corporation (6506) | Komori